JSPR - Wall Street Estimates - Jasper Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 5.51

3.18 %

$ 82.7 M

Market Cap

-1.16

P/E

Price Target Average

1067.57%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

7.50%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Jasper Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for JSPR of $64.3 , with forecasts ranging from a low of $63 to a high of $65 .

JSPR Lowest Price Target Wall Street Target

63 USD 1043.38%

JSPR Average Price Target Wall Street Target

64.3 USD 1067.57%

JSPR Highest Price Target Wall Street Target

65 USD 1079.67%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free